{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T14:20:16Z","timestamp":1770560416990,"version":"3.49.0"},"reference-count":22,"publisher":"Oxford University Press (OUP)","issue":"20","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,10,18]]},"DOI":"10.1093\/jnci\/djj422","type":"journal-article","created":{"date-parts":[[2006,10,18]],"date-time":"2006-10-18T00:33:34Z","timestamp":1161131614000},"page":"1432-1434","source":"Crossref","is-referenced-by-count":11,"title":["Helicobacter pylori Infection: Mainly Foe but Also Friend?"],"prefix":"10.1093","volume":"98","author":[{"given":"Olof","family":"Nyr\u00e9n","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William J.","family":"Blot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2006,10,18]]},"reference":[{"key":"key\n\t\t\t\t20171012232652_BIB1","doi-asserted-by":"crossref","unstructured":"Ford AC, Delaney BC, Forman D, Moayyedi P. Eradication therapy for peptic ulcer disease in Helicobacter pylori positive patients. Cochrane Database Syst Rev 2006 :CD003840.","DOI":"10.1002\/14651858.CD003840.pub4"},{"key":"key\n\t\t\t\t20171012232652_BIB2","doi-asserted-by":"crossref","unstructured":"Eslick GD. Helicobacter pylori infection causes gastric cancer? A review of the epidemiological, meta-analytic, and experimental evidence. World J Gastroenterol2006 ; 12 : 2991 \u20139.","DOI":"10.3748\/wjg.v12.i19.2991"},{"key":"key\n\t\t\t\t20171012232652_BIB3","doi-asserted-by":"crossref","unstructured":"Huang JQ, Zheng GF, Sumanac K, Irvine EJ, Hunt RH. Meta-analysis of the relationship between cagA seropositivity and gastric cancer. Gastroenterology2003 ; 125 : 1636 \u201344.","DOI":"10.1053\/j.gastro.2003.08.033"},{"key":"key\n\t\t\t\t20171012232652_BIB4","doi-asserted-by":"crossref","unstructured":"Ekstrom AM, Held M, Hansson LE, Engstrand L, Nyren O. Helicobacter pylori in gastric cancer established by CagA immunoblot as a marker of past infection. Gastroenterology2001 ; 121 : 784 \u201391.","DOI":"10.1053\/gast.2001.27999"},{"key":"key\n\t\t\t\t20171012232652_BIB5","doi-asserted-by":"crossref","unstructured":"Sorberg M, Engstrand L, Strom M, Jonsson KA, Jorbeck H, Granstrom M. The diagnostic value of enzyme immunoassay and immunoblot in monitoring eradication of Helicobacter pylori. Scand J Infect Dis1997 ; 29 : 147 \u201351.","DOI":"10.3109\/00365549709035875"},{"key":"key\n\t\t\t\t20171012232652_BIB6","doi-asserted-by":"crossref","unstructured":"Danesh J. Helicobacter pylori infection and gastric cancer: systematic review of the epidemiological studies. Aliment Pharmacol Ther1999 ; 13 : 851 \u20136.","DOI":"10.1046\/j.1365-2036.1999.00546.x"},{"key":"key\n\t\t\t\t20171012232652_BIB7","doi-asserted-by":"crossref","unstructured":"Helicobacter and Cancer Collaborative Group. Gastric cancer and Helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts. Gut2001 ; 49 : 347 \u201353.","DOI":"10.1136\/gut.49.3.347"},{"key":"key\n\t\t\t\t20171012232652_BIB8","doi-asserted-by":"crossref","unstructured":"Kamangar F, Dawsey SM, Blaser MJ, Perez-Perez GI, Pietinen P, Newschaffer CJ, et al. Opposing risks of gastric cardia and noncardia gastric adenocarcinoma associated with Helicobacter pylori seropositivity. J Natl Cancer Inst2006 ; 98 : 1445 \u201352.","DOI":"10.1093\/jnci\/djj393"},{"key":"key\n\t\t\t\t20171012232652_BIB9","doi-asserted-by":"crossref","unstructured":"Hansen S, Melby KK, Aase S, Jellum E, Vollset SE. Helicobacter pylori infection and risk of cardia cancer and non-cardia gastric cancer. A nested case-control study. Scand J Gastroenterol1999 ; 34 : 353 \u201360.","DOI":"10.1080\/003655299750026353"},{"key":"key\n\t\t\t\t20171012232652_BIB10","unstructured":"Chow WH, Blaser MJ, Blot WJ, Gammon MD, Vaughan TL, Risch HA, et al. An inverse relation between cagA+ strains of Helicobacter pylori infection and risk of esophageal and gastric cardia adenocarcinoma. Cancer Res1998 ; 58 : 588 \u201390."},{"key":"key\n\t\t\t\t20171012232652_BIB11","doi-asserted-by":"crossref","unstructured":"Siman HJ, Forsgren A, Berglund G, Floren CH. Helicobacter pylori infection is associated with a decreased risk of developing oesophageal neoplasms. Helicobacter2001 ; 6 : 310 \u20136.","DOI":"10.1046\/j.1523-5378.2001.00041.x"},{"key":"key\n\t\t\t\t20171012232652_BIB12","doi-asserted-by":"crossref","unstructured":"Ye W, Held M, Lagergren J, Engstrand L, Blot WJ, McLaughlin JK, et al. Helicobacter pylori infection and gastric atrophy: risk of adenocarcinoma and squamous-cell carcinoma of the esophagus and adenocarcinoma of the gastric cardia. J Natl Cancer Inst2004 ; 96 : 388 \u201396.","DOI":"10.1093\/jnci\/djh057"},{"key":"key\n\t\t\t\t20171012232652_BIB13","doi-asserted-by":"crossref","unstructured":"de Martel C, Llosa AE, Farr SM, Friedman GD, Vogelman JH, Orentreich N, et al. Helicobacter pylori infection and the risk of development of esophageal adenocarcinoma. J Infect Dis2005 ; 191 : 761 \u20137.","DOI":"10.1086\/427659"},{"key":"key\n\t\t\t\t20171012232652_BIB14","doi-asserted-by":"crossref","unstructured":"Wu AH, Crabtree JE, Bernstein L, Hawtin P, Cockburn M, Tseng CC, et al. Role of Helicobacter pylori CagA+ strains and risk of adenocarcinoma of the stomach and esophagus. Int J Cancer2003 ; 103 : 815 \u201321.","DOI":"10.1002\/ijc.10887"},{"key":"key\n\t\t\t\t20171012232652_BIB15","doi-asserted-by":"crossref","unstructured":"Sung JJ, Lin SR, Ching JY, Zhou LY, To KF, Wang RT, et al. Atrophy and intestinal metaplasia one year after cure of H. pylori infection: a prospective, randomized study. Gastroenterology2000 ; 119 : 7 \u201314.","DOI":"10.1053\/gast.2000.8550"},{"key":"key\n\t\t\t\t20171012232652_BIB16","doi-asserted-by":"crossref","unstructured":"Correa P, Fontham ET, Bravo JC, Bravo LE, Ruiz B, Zarama G, et al. Chemoprevention of gastric dysplasia: randomized trial of antioxidant supplements and anti-helicobacter pylori therapy. J Natl Cancer Inst2000 ; 92 : 1881 \u20138.","DOI":"10.1093\/jnci\/92.23.1881"},{"key":"key\n\t\t\t\t20171012232652_BIB17","doi-asserted-by":"crossref","unstructured":"Wong BC, Lam SK, Wong WM, Chen JS, Zheng TT, Feng RE, et al. Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. JAMA2004 ; 291 : 187 \u201394.","DOI":"10.1001\/jama.291.2.187"},{"key":"key\n\t\t\t\t20171012232652_BIB18","doi-asserted-by":"crossref","unstructured":"Leung WK, Lin SR, Ching JY, To KF, Ng EK, Chan FK, et al. Factors predicting progression of gastric intestinal metaplasia: results of a randomised trial on Helicobacter pylori eradication. Gut2004 ; 53 : 1244 \u20139.","DOI":"10.1136\/gut.2003.034629"},{"key":"key\n\t\t\t\t20171012232652_BIB19","doi-asserted-by":"crossref","unstructured":"Mera R, Fontham ET, Bravo LE, Bravo JC, Piazuelo MB, Camargo MC, et al. Long term follow up of patients treated for Helicobacter pylori infection. Gut2005 ; 54 : 1536 \u201340.","DOI":"10.1136\/gut.2005.072009"},{"key":"key\n\t\t\t\t20171012232652_BIB20","doi-asserted-by":"crossref","unstructured":"You WC, Brown LM, Zhang L, Li JY, Jin ML, Chang YS, et al. Randomized double-blind factorial trial of three treatments to reduce the prevalence of precancerous gastric lesions. J Natl Cancer Inst2006 ; 98 : 974 \u201383.","DOI":"10.1093\/jnci\/djj264"},{"key":"key\n\t\t\t\t20171012232652_BIB21","doi-asserted-by":"crossref","unstructured":"Malfertheiner P, Sipponen P, Naumann M, Moayyedi P, M\u00e9graud F, Xiao S-D, et al. Helicobacter pylori eradication has the potential to prevent gastric cancer: a state-of-the-art critique. Am J Gastroenterol2005 ; 100 ; 2100 \u201315.","DOI":"10.1111\/j.1572-0241.2005.41688.x"},{"key":"key\n\t\t\t\t20171012232652_BIB22","doi-asserted-by":"crossref","unstructured":"Graham DY, Shiotani A. The time to eradicate gastric cancer is now. Gut2005 ; 54 : 735 \u20138.","DOI":"10.1136\/gut.2004.056549"}],"container-title":["JNCI: Journal of the National Cancer Institute"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jnci\/article-pdf\/98\/20\/1432\/7687954\/djj422.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,21]],"date-time":"2019-04-21T21:34:43Z","timestamp":1555882483000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/jnci\/article\/98\/20\/1432\/2521864\/Helicobacter-pylori-Infection-Mainly-Foe-but-Also"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,10,18]]},"references-count":22,"journal-issue":{"issue":"20","published-online":{"date-parts":[[2006,10,18]]},"published-print":{"date-parts":[[2006,10,18]]}},"URL":"https:\/\/doi.org\/10.1093\/jnci\/djj422","relation":{},"ISSN":["1460-2105","0027-8874"],"issn-type":[{"value":"1460-2105","type":"electronic"},{"value":"0027-8874","type":"print"}],"subject":[],"published-other":{"date-parts":[[2006,10,18]]},"published":{"date-parts":[[2006,10,18]]}}}